IRIC's Core Facility Pricing Updated July 11th, 2014

Size: px
Start display at page:

Download "IRIC's Core Facility Pricing Updated July 11th, 2014"

Transcription

1 IRIC's Core Facility Pricing Updated July 11th, 2014 For information, please contact BIO-IMAGING - rate per hour Confocal $ $ $ $ Axio-Imager and others $ $ $ $ BIO-INFORMATICS - rate per hour Bioinformatician $ $ $ $ FLOW CYTOMETRY - rate per hour Analysis BD LSR II, self operator $ $ $ $ BD LSR II, with assistance $ $ $ $ BD LSR II with High troughput sampler, self operator $ $ $ $ BD LSR II with High troughput sampler, with assistance $ $ $ $ BD FACSCanto II, self operator $ $ $ $ BD FACSCanto II, with assistance $ $ $ $ ique screener, self operator $ $ $ $ ique screener, with assistance $ $ $ $ Sorting BD FACS Aria $ $ $ $ AutoMacs (per sample) $ $ $ $ Data analysis or Consultation $ $ $ $ HIGH THROUGHPUT SCREENING Plate reader (per hour) Envision (Perkin-Elmer) 40 $ 40 $ 60 $ 100 $ SpectraMax (Molecular Devices) 40 $ 40 $ 60 $ 100 $ Synergy Neo (Biotek) 40 $ 40 $ 60 $ 100 $ Operetta (Perkin-Elmer) 10 $ 10 $ 20 $ 40 $ Biomek FX (Beckman) 100 $ 100 $ 140 $ 200 $ Integrated robotic system (per hour) 100 $ 100 $ 140 $ 200 $ Technical assistance, data analysis & consultancy (per hour) 45 $ 45 $ 60 $ 130 $ Page 1 de 10

2 GENOMICS - rate per sample Sanger sequencing Sequencing reactions 7.40 $ 7.90 $ 8.40 $ $ Sequencing reactions (>384 samples) 5.30 $ 6.30 $ 7.40 $ $ Sequencing - BAC extremities $ $ $ $ ABI 3730 sequencer plate read - 96-well $ $ $ $ qpcr - gene expression analysis qpcr assay with UPL probe (design and validation) $ $ $ $ Reverse transcription - cdna synthesis 7.20 $ 7.69 $ 8.18 $ $ Reverse transcription - cdna synthesis > $ 6.41 $ 6.82 $ $ Reverse transcription - cdna synthesis > $ 5.24 $ 5.57 $ 8.38 $ DNAse treatment of RNA sample 3.20 $ 3.70 $ 4.20 $ 5.30 $ qpcr reaction with UPL probe 1.56 $ 1.67 $ 1.77 $ 2.67 $ qpcr reaction with UPL probe > $ 1.38 $ 1.46 $ 2.20 $ qpcr reaction with SYBR green 1.15 $ 1.23 $ 1.30 $ 1.96 $ qpcr reaction - Low Density Array (excluding array) 0.36 $ 0.39 $ 0.41 $ 0.62 $ qpcr plate read wells $ $ $ $ cdna pre-amplification $ $ $ $ Bioanalyzer - sample quality control Bioanalyzer RNA Nano (1 to 12 samples) $ $ $ $ Bioanalyzer RNA Pico (1 to 11 samples) $ $ $ $ Bioanalyzer DNA (1 to 12 samples) $ $ $ $ Bioanalyzer DNA High Sensitivity (1 to 11 samples) $ $ $ $ Next-generation sequencing (Illumina HiSeq 2000) Sequencing on the HiSeq2000, 200 cycles Sequencing on the MiSeq, 50 cycles Transcriptome (RNA seq) Genome (DNA seq) Exome Genomic regions of interest Small RNAs Quality control of libraries Contact us for a quote : Page 2 de 10

3 HISTOLOGY Paraffin Processing and embedding (per block) 2.84 $ 3.90 $ 5.60 $ 6.50 $ Decalcification (per cassette) 1.86 $ 2.24 $ 2.99 $ 3.50 $ Cassetting (per cassette) 2.07 $ 2.27 $ 2.50 $ 3.50 $ Microtome sections (per slide) 1.73 $ 2.40 $ 3.20 $ 3.70 $ Step sections (per slide) 1.94 $ 2.61 $ 3.28 $ 4.00 $ Additional sections (per section) 0.43 $ 0.68 $ 0.92 $ 2.50 $ H&E (per slide) 2.20 $ 2.41 $ 3.00 $ 3.97 $ HPS (per slide) 2.51 $ 2.71 $ 2.92 $ 4.09 $ FFPE complete service: processing, embedding, 1 section, 1 H&E (per block) 5.64 $ 7.82 $ 9.99 $ $ Frozen Tissue Freezing/OCT (per block) 2.35 $ 3.00 $ 3.25 $ 4.50 $ Cryostat sections (per slide) 2.73 $ 3.72 $ 4.72 $ 5.95 $ H&E (per slide) 1.31 $ 1.81 $ 2.31 $ 2.92 $ Frozen complete service: OCT, 1 section, 1 H&E (per block) 5.31 $ 7.37 $ 9.43 $ $ Histological stains (per slide) (other stains available upon request) Toluidine blue 3.76 $ 4.13 $ 4.96 $ 6.95 $ Gram 7.94 $ 8.74 $ $ $ Groccot 5.69 $ 6.26 $ 7.51 $ $ May Grunwald Giemsa 6.32 $ 6.95 $ 8.34 $ $ Movatt's 7.94 $ 8.74 $ $ $ Nuclear Fast Red 3.16 $ 3.48 $ 4.50 $ 5.84 $ PAS 4.27 $ 4.70 $ 6.50 $ 8.00 $ PAS - Alcian Blue 6.32 $ 6.95 $ 8.34 $ $ Sirius red 5.81 $ 6.39 $ 7.67 $ $ Masson's Trichrome 6.92 $ 7.61 $ 9.13 $ $ Von Kossa 7.60 $ 8.36 $ $ $ IHC/IF (per slide) (Biomarkers list available upon request) IHC without Iry antibody $ $ $ $ IF (TxRed or FITC) without Iry antibody $ $ $ $ IHC multimer without Iry antibody $ $ $ $ Dual stain without Iry antibody $ $ $ $ Consultation for antibody optimization (per hour) $ $ $ $ Tissue Microarray (TMA) TMA tissue plug (per core) 3.69 $ 5.13 $ 6.40 $ 9.18 $ TMA sections (per TMA) 3.18 $ 4.43 $ 5.55 $ 7.96 $ Page 3 de 10

4 HISTOLOGY Imaging - Analysis Scan - 20X (per slide) 4.31 $ 6.46 $ 7.60 $ 9.72 $ Scan - 40X (per slide) 9.72 $ $ $ $ Scan - 20X Fluo (per slide) 4.47 $ 6.83 $ 8.35 $ $ Scan - 40X Fluo (per slide) 9.72 $ $ $ $ Data storage (per GO/3 months) 1.10 $ 1.63 $ 2.15 $ 5.41 $ Image analysis protocol setup (per hour) $ $ $ $ Quantitative analysis 6.99 $ $ $ $ LMD usage without assistance (per hour) $ $ $ $ Fluorescence microscope usage / photographs without assistance (per hour) $ $ $ $ Analysis by the pathologist (per hour) $ $ $ $ Other Services Technical assistance (per hour) $ $ $ $ Miscellaneous DVD (per DVD) 0.85 $ 0.85 $ 0.85 $ 1.11 $ LMD membrane slides (per slide) 5.06 $ 5.06 $ 5.06 $ 6.58 $ LMD collection caps (per tube) 4.28 $ 4.28 $ 4.28 $ 5.56 $ Slide box X30 (per box) 1.76 $ 1.76 $ 1.76 $ 2.29 $ Slide box X100 (per box) 3.69 $ 3.69 $ 3.69 $ 4.80 $ Micro - cassettes (per cassette) 1.45 $ 1.45 $ 1.45 $ 1.89 $ Macro - cassettes (per cassette) 0.40 $ 0.40 $ 0.40 $ 0.52 $ Pad (per pad) 0.27 $ 0.27 $ 0.27 $ 0.35 $ Blades for trimming (per blade) 2.10 $ 2.10 $ 2.10 $ 2.73 $ Page 4 de 10

5 NMR-BIOPHYSICS - rate per hour NMR Sample preparation $ $ $ $ 600 MHz Cold Probe - set up $ $ $ $ 600 MHz Cold Probe - long runs 2.35 $ 2.50 $ 2.60 $ $ 600 MHz Cold Probe - short runs (<24 hours) $ $ $ $ 600 MHz Cold Probe - automated procedures $ $ $ $ Data processing $ $ $ $ Data analysis* $ $ $ $ Training - NMR $ $ $ $ Training - analysis, calculations $ $ $ $ Analytical Ultra-Centrifuge (AUC) Start up fee $ $ $ $ Assembly/cleaning $ $ $ $ Sedimentation velocity (~10 hours) $ $ $ $ Sedimentation equilibrium - flat rate (~24-48 hours) $ $ $ 1,260 $ Data analysis $ $ $ $ Circular Dichroism (CD) Run and basic analysis $ $ $ $ Data analysis $ $ $ $ Training - CD $ $ $ $ Fluorescence Run and basic analysis $ $ $ $ Training - Fluorescence $ $ $ $ Biophysics packages Basic - AUC, CD, (NMR), (fluorescence) 655 $ 740 $ 790 $ 2,100 $ Mutant - CD, AUC: altered structure, aggregation state 655 $ 740 $ 790 $ 2,100 $ Interaction - fluorescence, AUC, CD 1,312 $ 1,470 $ 1,580 $ 4,200 $ RNA/DNA - base pairing (NMR), Tm (CD) 1,312 $ 1,470 $ 1,580 $ 4,200 $ Structure - protein expression, labelling, NMR data collection, data analysis and structure determination** 13,135 $ 14,450 $ 15,760 $ 42,000 $ Computational Linux cluster (per hour) NMR analysis - $ - $ - $ 2.10 $ Strucutre calculations - ARIA/CYANA - $ - $ - $ 8.40 $ Strucutre calculations - cns - $ - $ - $ 2.10 $ Visualisation tools Training and analysis $ $ $ $ Movies $ $ $ $ *Fees for avanced analyses are subject to negotiation **Estimate for a 100 residue protein. Actual fee will be determined on a case per case basis Page 5 de 10

6 PROTEOMICS - rate per sample Sample preparation Liquid digestion $ $ $ $ 1D or 2D gel + silver staining (<8 samples) (per gel) $ $ $ $ Destaining (per gel) $ $ $ $ 1D/2D in-gel digestion + peptide extraction $ $ $ $ Phosphopeptide enrichment $ $ $ $ Mass spectrometry LC-MS or LC-MS/MS $ $ $ $ Long run LC-MS/MS $ $ $ $ 2D LC-MS/MS (6 sample fractions) $ $ $ 1,551 $ Exact Mass $ $ $ $ 2D spot analysis et MRM $ $ $ $ Analysis (per hour) $ $ $ $ Scaffold analysis $ $ $ $ Total - liquid digest + LC-MS/MS $ $ $ $ Total - destain, digest, extraction, LC-MS/MS* $ $ $ $ Total - gel, destain, digest, extraction, LC-MS/MS* $ $ $ $ *Price per sample, based on the processing of 8 samples TRANSGENESIS Pronuclear DNA microinjection Microinjection C57BL/6 5,000 $ 5,590 $ 6,429 $ 14,145 $ ES cells injection Blastocysts C57BL/6 3,657 $ 4,715 $ 5,400 $ 12,710 $ Morula CD1 3,657 $ 4,715 $ 5,400 $ 12,710 $ Blastocysts B6(Cg)Tyrc2j/j (albinos B6) 4,536 $ 6,075 $ 7,000 $ 12,710 $ Embryo Cryopreservation Tg x Tg (300 embryos) 1,790 $ 1,950 $ 2,250 $ 5,230 $ Homo x wt C57BL/6 (300 embryos) 2,000 $ 2,300 $ 2,650 $ 5,230 $ Hetero x wt C57BL/6 (600 embryos) 3,300 $ 3,800 $ 4,370 $ 5,230 $ Storage in liquid nitrogen (per strain/month) 4 $ 6 $ 8 $ 10 $ Thawing and reimplantation (cryo procedure performed at IRIC) 660 $ 780 $ 900 $ 2,050 $ Sperm Cryopreservation Cryo and validation by IVF reimplantation 680 $ 795 $ 900 $ 2,155 $ Storage in liquid nitrogen (per strain/month) 4 $ 6 $ 8 $ 10 $ Thawing and reimplantation (cryo procedure performed at IRIC) 1,130 $ 1,330 $ 1,500 $ 3,590 $ In vitro fertilization (Fresh Sperm) FIV C57BL/6 1,130 $ 1,330 $ 1,500 $ 3,590 $ Rederivation Tg x Tg 1,200 $ 1,435 $ 1,650 $ 3,795 $ Homo or Hetero x wt C57BL/6 1,200 $ 1,435 $ 1,650 $ 3,795 $ Sperm - external source (Thawing, IVF et reimplantation) 1,300 $ 1,530 $ 1,600 $ 3,590 $ Embryos - external source (Thawing, IVF et reimplantation) 710 $ 830 $ 950 $ 2,050 $ Page 6 de 10

7 BIOPHARMACY - Pharmacy faculty - Jean-Coutu building ADMET, PK et bioanalysis CYTOGENETICS - HMR ( Contact us for a quote : Mouse cytogenetic services Cells harvesting (suspension cell culture) $ $ $ $ Cells harvesting (adherent cell culture) $ $ $ $ Standard G-banding Karyotyping G-banding preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Analysis of 20 metaphases and karyotyping $ $ $ $ Verification and validation of the karyotypes $ $ $ $ Preparation and print of 5 karyotypes $ $ $ $ Basic price $ $ $ $ * For complex karyotype : see pricing for complex karyotype by SKY Chromosome breakage studies Preparation of different alkylating agents $ $ $ $ Standard Giemsa preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Chromosome breakage count of 50 cells (less than 5 breakages/cell) $ $ $ $ Verification and validation of the breakagestudies $ $ $ $ Preparation and print of images $ $ $ $ Basic price $ $ $ $ Complex breakage $ 1,350 $ 1,720 $ 2,150 $ Giemsa stain and chromosome count G-banding preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Chromosomes counting $ $ $ $ Verification and validation of the analysis 8.75 $ $ $ $ Preparation and print of images $ $ $ $ Basic price $ $ $ $ Page 7 de 10

8 FISH (BACs) BAC probe $ $ $ $ BAC extraction $ $ $ $ BAC labelling $ $ $ $ FISH technique (hybridization, washing, detection) for BAC validation on a control slide $ $ $ $ BAC validation on metaphases (microscopy analysis) 8.75 $ $ $ $ FISH technique (hybridization, washing, detection) for BAC study on the test sample $ $ $ $ Search and capture of metaphases $ $ $ $ Verification and validation of the analysis $ $ $ $ Preparation and print of FISH images $ $ $ $ Final rapport $ $ $ $ Basic price $ $ 1,096 $ 1,370 $ Spectral Karyotyping (SKY) Mouse & Rat SKY technique (hybridization, washing, detection) $ $ $ 1,088 $ Search and capture of metaphases $ $ $ $ Karyotyping and metaphases anlaysing $ $ $ $ Verification and validation of the spectral karyotypes $ $ $ $ Preparation and print of spectral karyotypes (SKY) $ $ $ $ Final report $ $ $ $ Basic price 1,129 $ 1,358 $ 1,578 $ 1,973 $ *Spectral Karyotyping (SKY) Mouse & Rat cell line with complex karyotype 2,490 $ 2,570 $ 3,150 $ 3,938 $ Human Cytogenetics Services Cells harvesting (suspension cell culture) $ $ $ $ Cells harvesting (adherent cell culture) $ $ $ $ Standard G-banding karyotyping G-banding preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Analysis of 20 metaphases and karyotyping $ $ $ $ Verification and validation of the karyotypes $ $ $ $ Preparation and print of 5 karyotypes $ $ $ $ Basic price $ $ $ $ Complex karyotype (G-banding) $ $ 1,060 $ 1,325 $ Page 8 de 10

9 Chromosome breakage studies Preparation of different alkylating agents $ $ $ $ Standard Giemsa preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Chromosome breakage count of 50 cells (less than 5 breakages/cell) $ $ $ $ Verification and validation of the analysis $ $ $ $ Preparation and print of images $ $ $ $ Basic price $ $ $ $ Complex $ 1,350 $ 1,720 $ 2,150 $ Giemsa stain and chromosome count G-banding preparation $ $ $ $ Search and capture of metaphases $ $ $ $ Chromosomes counting $ $ $ $ Verification and validation of the analysis 8.75 $ $ $ $ Preparation and print of images 8.75 $ $ $ $ Basic price $ $ $ $ FISH (commercial probe) Commercial probe $ $ $ $ FISH technique (hybridization, washing, detection) $ $ $ $ Count, analysis, image capture $ $ $ $ Verification and validation of the analysis 8.75 $ $ $ $ Preparation and print of FISH images 8.75 $ $ $ $ Basic price $ $ $ $ FISH (BACs) BAC probe $ $ $ $ BAC extraction $ $ $ $ BAC labelling $ $ $ $ FISH technique (hybridization, washing, detection) for BAC validation on a control slide $ $ $ $ Page 9 de 10

10 BAC validation on metaphases (microscopy analysis) 8.75 $ $ $ $ FISH technique (hybridization, washing, detection) for BAC study on the test sample $ $ $ $ Search and capture of metaphases $ $ $ $ Verification and validation of the analysis $ $ $ $ Preparation and print of FISH images $ $ $ $ Final report $ $ $ $ Basic price $ $ 1,096 $ 1,371 $ Human Cytogenetics Services FISH (Fosmids) Fosmid probe $ $ $ $ Fosmid extraction $ $ $ $ Fosmid labelling $ $ $ $ FISH technique (hybridization, washing, detection) for Fosmid validation on a control slide $ $ $ $ Fosmid validation on metaphases (microscopy analysis) 8.75 $ $ $ $ FISH technique (hybridization, washing, detection) for Fosmid study on the test sample $ $ $ $ Search and capture of metaphases $ $ $ $ Verification and validation of the analysis $ $ $ $ Preparation and print of FISH images $ $ $ $ Final report $ $ $ $ Basic price $ $ 1,096 $ 1,371 $ Spectral karyotyping (SKY) Human quality and mitotic index evaluat $ $ $ $ SKY technique (hybridization, washing, detection) $ $ $ $ Search and capture of metaphases $ $ $ $ Karyotyping and metaphases anlaysis $ $ $ $ Verification and validation of the analysis $ $ $ $ Preparation and print of spectral karyotypes (SKY) $ $ $ $ Final report $ $ $ $ Basic price $ 1,195 $ 1,415 $ 1,769 $ *Spectral Karyotyping (SKY) human sample with complex karyotype 2,100 $ 2,500 $ 2,900 $ 3,625 $ Karyotype analysis by a cytogeneticist (per hour) $ $ $ $ Page 10 de 10

The following are the revised In-Vivo Animal Core (IVAC) rates that have been reviewed and approved by the University s Financial Analysis Office.

The following are the revised In-Vivo Animal Core (IVAC) rates that have been reviewed and approved by the University s Financial Analysis Office. IVAC ADL 1 Chemistry / animal $ 16.65 $ 16.65 2 Chemistries / animal $ 27.06 $ 27.06 3 Chemistries / animal $ 34.33 $ 34.33 4 Chemistries / animal $ 40.03 $ 40.03 5 Chemistries / animal $ 45.41 $ 45.41

More information

Managing Core Facilities

Managing Core Facilities Managing Core Facilities Sonia C. Ashley, MAS Ira S. Goodman, MPA, MS, CRA Associate Director for Administration Director, Business Operations UC San Diego Moores Cancer Center UC San Diego Moores Cancer

More information

QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS

QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS Prepared by: Illumina, Inc. 9885 Towne Centre Drive San Diego, CA 92121-1975, USA Hereinafter referred to as Illumina Prepared for: Mount Sinai Hospital

More information

CPB principles for research loans between natural history collections

CPB principles for research loans between natural history collections CPB principles for research loans between natural history collections Introduction The following document was drafted and revised by the EDIT 1 Directors of Collections (DoC) group. It is based on the

More information

ANNUAL REPORT 2005 ILLUMINA INC 2005 A N N U A L REP O R T

ANNUAL REPORT 2005 ILLUMINA INC 2005 A N N U A L REP O R T ANNUAL REPORT 2005 3404124 Illumina helps researchers understand the genetic basis of disease. Shown on the cover are Sentrix HumanHap BeadChips, each of which can genotype hundreds of thousands of SNPs

More information

Nanogen Epoch Biosciences Merger Frequently Asked Questions

Nanogen Epoch Biosciences Merger Frequently Asked Questions Filed by Nanogen, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Epoch Biosciences, Inc.

More information

Quotation for Histology Laboratory and General Clinical Laboratory Services

Quotation for Histology Laboratory and General Clinical Laboratory Services GENESEE COUN TY PURCHASING A Division of the Genesee County Controller s Office COUNTY ADMINISTRATION BLDG 1101 BEACH STREET, ROOM 343, FLINT, MICHIGAN 48502 Phone: (810) 257 3030 Fax (810)257 3380 www.gc4me.com

More information

Bruker Corporation (NASDAQ: BRKR)

Bruker Corporation (NASDAQ: BRKR) Bruker Corporation (NASDAQ: BRKR) Bruker drives profitable growth by enabling scientific discoveries and delivering high-performance analytical, life science and diagnostic solutions. Bruker Corporation

More information

NEOGENOMICS, INC. (Exact name of registrant as specified in its charter)

NEOGENOMICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended

More information

Innovation with Integrity. November 15, Bruker Corporation

Innovation with Integrity. November 15, Bruker Corporation Bruker drives profitable growth and margin expansion by enabling scientific discoveries and by delivering highperformance analytical, life science and diagnostic solutions November 15, 2017 Innovation

More information

Bruker Corporation (NASDAQ: BRKR)

Bruker Corporation (NASDAQ: BRKR) Bruker Corporation (NASDAQ: BRKR) Q2 2018 Earnings Presentation August 2, 2018 Frank Laukien, President & CEO Gerald Herman, Chief Financial Officer Miroslava Minkova, Director of Investor Relations &

More information

Genomics and Insurance. 30 November 2018 Julie Scott Underwriting Proposition Manager Munich Re UKLB Tel: +44 (20)

Genomics and Insurance. 30 November 2018 Julie Scott Underwriting Proposition Manager Munich Re UKLB Tel: +44 (20) Genomics and Insurance 30 November 2018 Julie Scott Underwriting Proposition Manager Munich Re UKLB jscott@munichre.com Tel: +44 (20) 3650 7635 0 Introduction NOCA - Genomics and Insurance - Julie Scott

More information

ILLUMINA INC (ILMN) 10-K

ILLUMINA INC (ILMN) 10-K ILLUMINA INC (ILMN) 10-K Annual report pursuant to section 13 and 15(d) Filed on 02/24/2012 Filed Period 01/01/2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K þ ANNUAL

More information

Exhibit Space Application and Contract

Exhibit Space Application and Contract Exhibit Space Application and Contract Apply for Exhibit Space via email, fax, or mail. Email: jdahlroth@acmg.net Fax: (703) 783-0501 Mail: ACMG Exhibits, 7101 Wisconsin Avenue, Suite 1101, Bethesda, MD

More information

FACS staining of human breast cancer cores for ALDH, CD24, CD44, EpCAM, and Lineage negative cells

FACS staining of human breast cancer cores for ALDH, CD24, CD44, EpCAM, and Lineage negative cells .0 Purpose The purpose of SOP is to describe FAC staining of human breast primary tissue for ALDH, and lineage. 2.0 Scope SOP is intended to cover all resources, personnel and equipment in the BCR laboratory.

More information

Annual Report 2002 Bringing innovation to the Life Sciences

Annual Report 2002 Bringing innovation to the Life Sciences Annual Report Bringing innovation to the Life Sciences TECAN PROFILE Tecan is a leading player in the Life Sciences supply industry. The company specializes in the development, production, and distribution

More information

Assessment performed on Friday, May 26, 2017, at Vancouver General Hospital, BC, Canada

Assessment performed on Friday, May 26, 2017, at Vancouver General Hospital, BC, Canada Assessors report for ciqc Run 68: p53 Assessors: B Gilks, J Garratt, J Won (recorder) Assessment performed on Friday, May 26, 2017, at Vancouver General Hospital, BC, Canada Overview Interpretation of

More information

Operating Results & Financial Position, Ended March 2014 President & CEO Akira Nakamoto Shimadzu Corporation

Operating Results & Financial Position, Ended March 2014 President & CEO Akira Nakamoto Shimadzu Corporation May 13 2014 Operating Results & Financial Position, Ended March 2014 President & CEO Akira Nakamoto Shimadzu Corporation Financial Highlights Net Sales 307.5 264.0 43.5 16.5 Operating Income 24.0 12.1

More information

Agilent Technologies. 33 rd Annual J.P. Morgan Healthcare Conference. Mike McMullen President and COO. Page 1

Agilent Technologies. 33 rd Annual J.P. Morgan Healthcare Conference. Mike McMullen President and COO. Page 1 Agilent Technologies 33 rd Annual J.P. Morgan Healthcare Conference Mike McMullen President and COO Page 1 Safe Harbor This presentation contains forward-looking statements (including, without limitation,

More information

Session 3. Life/Health Insurance technical session

Session 3. Life/Health Insurance technical session SOA Big Data Seminar 13 Nov. 2018 Jakarta, Indonesia Session 3 Life/Health Insurance technical session Anilraj Pazhety Life Health Technical Session ANILRAJ PAZHETY MS (BUSINESS ANALYTICS), MBA, BE (CS)

More information

Designated Unclassified Subject Areas (DUSAs)

Designated Unclassified Subject Areas (DUSAs) February 1995 LALP-95-10 L o s A l a m o s N a t i o n a l L a b o r a t o r y Classification Group (FSS-16) Designated Unclassified Subject Areas (DUSAs) Program Information and User's Guide Los Alamos

More information

Call Outline. Forward Looking Statements. First Quarter 2007 Earnings Conference Call

Call Outline. Forward Looking Statements. First Quarter 2007 Earnings Conference Call Call Outline May 8, 2007, 9:30am EDT, 14:30 GMT, 15:30 CET First Quarter 2007 Earnings Conference Call Conference Call Outline: 1) 30 min Presentation Peer M. Schatz, CEO Roland Sackers, CFO Dr. Solveigh

More information

PRESSURE BIOSCIENCES, INC. (Exact Name of Registrant as Specified in its Charter)

PRESSURE BIOSCIENCES, INC. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period

More information

2017 Annual Report. Innovation with Integrity. Bruker Corporation 4/4/18 3:58 PM

2017 Annual Report. Innovation with Integrity. Bruker Corporation 4/4/18 3:58 PM 2017 Annual Report Bruker Corporation Innovation with Integrity 4/4/18 3:58 PM Bruker s high-performance scientific instruments and high-value analytical tools and diagnostic solutions visualize, analyze

More information

NeoGenomics. Investor Presentation. June 2018

NeoGenomics. Investor Presentation. June 2018 NeoGenomics Investor Presentation June 2018 This presentation has been prepared by NeoGenomics, Inc. ( we, us, our, NeoGenomics or the Company ) and is made for informational purposes only and does not

More information

CANCER GENETICS, INC.

CANCER GENETICS, INC. As filed with the Securities and Exchange Commission on May 7, 2012 Registration No. 333-178836 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware (State or other jurisdiction

More information

CALCULATION OF THE MINIMUM NUMBER OF REPLICATE SPOTS REQUIRED FOR DETECTION OF SIGNIFICANT GENE EXPRESSION FOLD CHANGE IN MICROARRA Y EXPERIMENTS

CALCULATION OF THE MINIMUM NUMBER OF REPLICATE SPOTS REQUIRED FOR DETECTION OF SIGNIFICANT GENE EXPRESSION FOLD CHANGE IN MICROARRA Y EXPERIMENTS Libraries Annual Conference on Applied Statistics in Agriculture 21-13th Annual Conference Proceedings CALCULATION OF THE MINIMUM NUMBER OF REPLICATE SPOTS REQUIRED FOR DETECTION OF SIGNIFICANT GENE EXPRESSION

More information

Rosetta Genomics Reports Second Quarter 2010 Financial Results

Rosetta Genomics Reports Second Quarter 2010 Financial Results Rosetta Genomics Reports Second Quarter 2010 Financial Results Test Volume Increases 170% Compared With the First Quarter Conference Call Scheduled for Wednesday, September 8 th at 10:00 a.m. Eastern Time

More information

GE s DeltaVision OMX Microscope

GE s DeltaVision OMX Microscope GE s DeltaVision OMX Microscope SIM Theory, Sample Prep & Analysis Patrina Pellett, PhD Applications Scientist GE Healthcare, Cell Technologies May 27th, 2015 OMX Capabilities Summary 3D structured illumination

More information

Agilent Technologies. Q3'18 Results Presentation

Agilent Technologies. Q3'18 Results Presentation Agilent Technologies Q3'18 Results Presentation Safe Harbor This presentation contains forward-looking statements (including, without limitation, information and future guidance on the company s goals,

More information

Reverse Transcription Reagent

Reverse Transcription Reagent ExoComplete Reverse Transcription Reagent For cdna synthesis on mrna Capture Plate or mrna Capture 8-well Strip For use in real-time two-step qrt-pcr INSTRUCTION MANUAL For Research Use Only 630 Clyde

More information

IRIS TUBE INSPECTION. Item Inspected: Unit 123. Date Commenced: 01/01/2015. Date of Completed: 12/01/2015

IRIS TUBE INSPECTION. Item Inspected: Unit 123. Date Commenced: 01/01/2015. Date of Completed: 12/01/2015 IRIS TUBE INSPECTION Client: Client a Facility: site b Item Inspected: Inspection Method: IRIS (Ultrasonic) Date Commenced: 01/01/2015 Date of Completed: 12/01/2015 Type of Report: Report Number: K0xx-15

More information

Innovation with Integrity. Bruker Corporation

Innovation with Integrity. Bruker Corporation Bruker drives profitable growth and margin expansion by enabling scientific discoveries and by delivering highperformance analytical, life science and diagnostic solutions Bruker Corporation Innovation

More information

CANCER GENETICS, INC. (Exact name of registrant as specified in its charter)

CANCER GENETICS, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended

More information

PRESSURE BIOSCIENCES INC

PRESSURE BIOSCIENCES INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING PRESSURE BIOSCIENCES INC Form: 10-K Date Filed: 2013-05-13 Corporate Issuer CIK: 830656 Symbol: PBIO SIC Code: 3829 Fiscal Year End: 12/31 Copyright 2014,

More information

Building a Market Leader in Molecular Biology August 2018 Half Year Results 2018 & Outlook 2018

Building a Market Leader in Molecular Biology August 2018 Half Year Results 2018 & Outlook 2018 Enabling Innovation Building a Market Leader in Molecular Biology August 2018 Half Year Results 2018 & Outlook 2018 August 09, 2018 1 Today on the Call Heikki Lanckriet, PhD CEO/CSO David Roth CFO August

More information

FLUIDIGM. Patent Portfolio Analysis. KnowMade Patent & Technology Intelligence. May 2017

FLUIDIGM. Patent Portfolio Analysis. KnowMade Patent & Technology Intelligence. May 2017 FLUIDIGM Patent Portfolio Analysis May 2017 KnowMade Patent & Technology Intelligence 1 TABLE OF CONTENTS INTRODUCTION 5 Scope of the Report 6 Key Features of the Report 7 Objectives of the report 8 Key

More information

CANCER GENETICS, INC.

CANCER GENETICS, INC. As filed with the Securities and Exchange Commission on April 2, 2012 Registration No. 333-178836 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to Form S-1 REGISTRATION

More information

Summary of Consolidated Financial Results [ IFRS ] for the First Nine Months of the Fiscal Year Ending March 31, 2018 February 6, 2018

Summary of Consolidated Financial Results [ IFRS ] for the First Nine Months of the Fiscal Year Ending March 31, 2018 February 6, 2018 Summary of Consolidated Financial Results [ IFRS ] for the First Nine Months of the Fiscal Year Ending March 31, 2018 February 6, 2018 Listed company name : Sysmex Corporation Code : 6869 Listed stock

More information

Second Quarter 2008 Earnings Conference Call

Second Quarter 2008 Earnings Conference Call August 5, 2008, 9:30am EDT, 14:30 GMT, 15:30 CET Second Quarter 2008 Earnings Conference Call Conference Call Outline: 1) 30 min Presentation Peer M. Schatz, CEO Roland Sackers, CFO Dr. Solveigh Mähler,

More information

Bruker Corporation (Nasdaq: BRKR)

Bruker Corporation (Nasdaq: BRKR) Bruker Corporation (Nasdaq: BRKR) Bruker drives customer success and profitable growth by enabling scientific discoveries and delivering high-performance analytical, life science, pharmaceutical and diagnostic

More information

cbot User Guide T G AC CG C FOR RESEARCH USE ONLY ILLUMINA PROPRIETARY Catalog # SY Part # Rev C

cbot User Guide T G AC CG C FOR RESEARCH USE ONLY ILLUMINA PROPRIETARY Catalog # SY Part # Rev C cbot User Guide FOR RESEARCH USE ONLY ACGTACGTACGTACG TACGTACGTACGTACGTA A G T G AC CG C T AC CGT ILLUMINA PROPRIETARY Catalog # SY-920-1001 Part # 15006165 Rev C Notice This document and its contents

More information

Pathogen Detection Through Molecular Spectroscopy: Application of Surface-Enhanced Raman Scattering (SERS)

Pathogen Detection Through Molecular Spectroscopy: Application of Surface-Enhanced Raman Scattering (SERS) Pathogen Detection Through Molecular Spectroscopy: Application of Surface-Enhanced Raman Scattering (SERS) Dr. Timothy O. Deschaines Raman Product Specialist Presentation Overview Current techniques What

More information

Biomedical Applications. Digital Image Processing

Biomedical Applications. Digital Image Processing Biomedical Applications of Digital Image Processing Biomedical Applications of Digital Image Processing José Fonseca jmf@uninova.pt André Mora atm@uninova.pt OUTLINE Retinography applications Biology and

More information

ILMN Q4 & FY17 Summary of Prepared Remarks and Key Metrics. 30 January 2018

ILMN Q4 & FY17 Summary of Prepared Remarks and Key Metrics. 30 January 2018 ILMN Q4 & FY17 Summary of Prepared Remarks and Key Metrics 30 January 2018 Q417 Yr/Yr FY17 Yr/Yr Sequencing Consumables $432M +31 $1,468M +15 Primary contributor to the more than $100 million year-over-year

More information

For personal use only

For personal use only Advanced Molecular Diagnostic Systems 1 Dalmore Drive, Scoresby, Victoria 3179 AUSTRALIA T: +61 (0)3 9763-1287 F: +61 (0)3 9763-2817 www.generabiosystems.com Tuesday 31 January 2017 ASX Announcement GENERA

More information

Bio-Rad Laboratories Annual Report Focused On: the Details

Bio-Rad Laboratories Annual Report Focused On: the Details Bio-Rad Laboratories Annual Report 2009 Focused On: the Details Bio-Rad Laboratories Annual Report 2009 FOCUSED ON: OUR SHAREHOLDERS Most letters to shareholders this year will make some reference to the

More information

Fueling Next Generation Molecular Biology

Fueling Next Generation Molecular Biology Fueling Next Generation Molecular Biology Annual Report 2014 Key Figures Overview 2014 2013 (ends December 31) (ends December 31) STATEMENT OF COMPREHENSIVE INCOME Revenues 392 482 Research and development

More information

Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update

Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update May 18, 2016 Pressure BioSciences, Inc. Reports First Quarter 2016 Financial Results and Provides Business Update Quarterly Products and Services Revenue Increases 26% Year/Year; Sales of Instruments and

More information

QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS

QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS QUOTATION FOR SUPPLY OF GENETIC ANALYSIS PRODUCTS Prepared by: Illumina, Inc. 9885 Towne Centre Drive San Diego, CA 92121-1975, USA Hereinafter referred to as Illumina Prepared f: Mark Dasenko Oregon State

More information

Contents. Part II Statements 28 Statement by Executive Board and Supervisory Board on the Annual Report 29 Independent Auditor's Reports

Contents. Part II Statements 28 Statement by Executive Board and Supervisory Board on the Annual Report 29 Independent Auditor's Reports Annual Report 2015 Contents Part I Management Report 3 Exiqon 4 Five-Year Key Figures and Ratios 5 2015 Highlights 6 Exiqon Life Sciences 10 Exiqon Diagnostics 14 Risks 16 Financial Performance in 2015

More information

GRAMMATICAL EVOLUTION. Peter Černo

GRAMMATICAL EVOLUTION. Peter Černo GRAMMATICAL EVOLUTION Peter Černo Grammatical Evolution (GE) Is an evolutionary algorithm that can evolve programs. Representation: linear genome + predefined grammar. Each individual: variable-length

More information

IDEX CORPORATION. BAIRD 2008 Industrial Conference

IDEX CORPORATION. BAIRD 2008 Industrial Conference IDEX CORPORATION BAIRD 2008 Industrial Conference November 11, 2008 Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward-looking

More information

Bruker Corporation (NASDAQ: BRKR)

Bruker Corporation (NASDAQ: BRKR) Corporation (NASDAQ: BRKR) William Blair Growth Stock Conference June 12, 2013 Charles Wagner, CFO Joshua Young, VP, Investor Relations Corporation Safe Harbor Statement Any statements contained in this

More information

APPLERA CORPORATION ANNUAL REPORT

APPLERA CORPORATION ANNUAL REPORT ANNUAL REPORT 2006 A p p l i e d B i o s y s t e m s C e l e r a G e n o m i c s applera corporation consists of the following businesses: has two classes of common stock. Applera Corporation Applied Biosystems

More information

Life as a protein chemist

Life as a protein chemist Life as a protein chemist Ray Bacala University of Manitoba 06-Feb-17 CANADIAN GRAIN COMMISSION Corporate Services Grain Research Laboratory Grain quality assurance Quality testing (grading) Safety testing

More information

Machine Learning Applications in Insurance

Machine Learning Applications in Insurance General Public Release Machine Learning Applications in Insurance Nitin Nayak, Ph.D. Digital & Smart Analytics Swiss Re General Public Release Machine learning is.. Giving computers the ability to learn

More information

SOP: Human tpa Activity ELISA Kit

SOP: Human tpa Activity ELISA Kit Page 1 of 5 Approvals Preparer: Jason McMillan Reviewer: Dr. Margaret Bryans Date: 1APR14 Date: 11APR14 1. Purpose 1.1. Quantitative determination of active tpa 2. Scope and Applicability 2.1. Human tpa

More information

CareDx - Allenex Building a Comprehensive Global Transplant Diagnostics Leader. Investor Conference Call April 19, 2016

CareDx - Allenex Building a Comprehensive Global Transplant Diagnostics Leader. Investor Conference Call April 19, 2016 CareDx - Allenex Building a Comprehensive Global Transplant Diagnostics Leader Investor Conference Call April 19, 2016 Safe Harbor Statement These slides and the accompanying oral presentation contain

More information

Third consecutive profitable quarter with continued strong growth

Third consecutive profitable quarter with continued strong growth Interim report for the period 1 January 30 September 2015 Announcement No. 10/2015 To NASDAQ Copenhagen Exiqon A/S Skelstedet 16 2950 Vedbæk Denmark 26 October 2015 Phone: +45 4566 0888 Fax: +45 4566 1888

More information

Tender for. Supply and Installation of DNA/RNA Fragment Analyzer System

Tender for. Supply and Installation of DNA/RNA Fragment Analyzer System Tender for Supply and Installation of DNA/RNA Fragment Analyzer System Tender No. CNS/IISC/JTTO/Fragment Analyzer/06/2018 Centre for Neuroscience Indian Institute of Science Bangalore 560012 November 2018

More information

BB22 BB22 BB22 BB22R1 BB22R1 BB22R1 BB22

BB22 BB22 BB22 BB22R1 BB22R1 BB22R1 BB22 Table 1. Summary of Results for 2D gel comparison of Pellets of Neisseria gonorrhoeae: BB22 vs. BB22R1. Reference spot numbering, pi, and MW are given for changing polypeptide spots analyzed in samples

More information

Lodgement of Federal Court orders with ASIC and suspension of trading in RHS shares

Lodgement of Federal Court orders with ASIC and suspension of trading in RHS shares ASX Release 30 May 2018 ACN 010 126 708 Lodgement of Federal Court orders with ASIC and suspension of trading in RHS shares Adelaide, 30 May 2018: RHS Limited (ASX: RHS) ( RHS or the Company ) announces

More information

Oxford Instruments plc

Oxford Instruments plc Oxford Instruments plc Report and Financial Statements 2018 Oxford Instruments plc is a leading provider of high technology products and services to the world s leading industrial companies and scientific

More information

ILMN Q418 Summary of Prepared Remarks

ILMN Q418 Summary of Prepared Remarks ILMN Q418 Summary of Prepared Remarks Q418 Yr/Yr Management Commentary Sequencing Consumables $466M 8% Reflects Yr/Yr growth across high throughput (HT), mid throughput (MT), and low throughput (LT) categories

More information

( TEST TSX-V) Ultra Sensitive Cannabis Testing

( TEST TSX-V) Ultra Sensitive Cannabis Testing ( TEST TSX-V) Ultra Sensitive Cannabis Testing Disclaimer: Forward-Looking Information 2 This presentation contains "forward-looking information" within the meaning of applicable securities legislation.

More information

Q SHAREHOLDER UPDATE CALL

Q SHAREHOLDER UPDATE CALL Q4 2015 SHAREHOLDER UPDATE CALL FIRST. TRANSFORMATIVE. PROVEN. TRANSFORMING THE FUTURE NASDAQ : TINY 1 SAFE HARBOR STATEMENT This presentation may contain statements of a forward-looking nature relating

More information

Automated exposure control Adjustment of the ma and/or kv according to patient size

Automated exposure control Adjustment of the ma and/or kv according to patient size Quality ID #436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Medical Malpractice. Fertility Clinics Proposal Form

Medical Malpractice. Fertility Clinics Proposal Form Medical Malpractice Fertility Clinics Proposal Form General Guidance Insurance is a contract of the utmost good faith. This means that the information you provide in this Proposal Form must be complete,

More information

RealLine Pathogen Diagnostic Kits

RealLine Pathogen Diagnostic Kits RealLine Pathogen Diagnostic Kits for Real Time PCR SEXUALLY TRANSMITTED INFECTIONS HUMAN PAPILLOMA VIRUS HUMAN HERPES VIRUS New Edition 2018 AND OTHERS New Product: RealLine HPV HCR Screen see page 5

More information

Fo c u. ed on Gro. n Ou r C u s. Fo c 2009 A N N UA L R E P O RT 2009 ANNUAL REPORT

Fo c u. ed on Gro. n Ou r C u s. Fo c 2009 A N N UA L R E P O RT 2009 ANNUAL REPORT T H E R MO FISH E R SC IE NTI FI C IN C. DESIGN: WWW.GROWDESIGN.COM wt h Fo c u ers Fo c us n Ou r C u s o t ed om 2009 A N N UA L R E P O RT T H E R M O F I S H E R S C I E N T I F I C IN C. 8 1 W Y M

More information

BIOCARTIS ANNOUNCES INTENTION TO LAUNCH AN INITIAL PUBLIC OFFERING ON EURONEXT BRUSSELS

BIOCARTIS ANNOUNCES INTENTION TO LAUNCH AN INITIAL PUBLIC OFFERING ON EURONEXT BRUSSELS THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL, OR AN INVITATION TO OFFER TO BUY OR SUBSCRIBE FOR, SECURITIES. INVESTORS WILL NEED TO BASE THEIR INVESTMENT DECISION ON THE PROSPECTUS AND PARTICULARLY

More information

INDIAN ASSOCITION FOR THE CULTIVATION OF SCIENCE 2A & 2B, Raja S.C. Mullick Road, Jadavpur, Kolkata

INDIAN ASSOCITION FOR THE CULTIVATION OF SCIENCE 2A & 2B, Raja S.C. Mullick Road, Jadavpur, Kolkata INDIAN ASSOCITION FOR THE CULTIVATION OF SCIENCE 2A & 2B, Raja S.C. Mullick Road, Jadavpur, Kolkata-700032 NIT No. : IACS/CAM/NRJ/2017-18/72 Date: 20/11/ 2017 Sealed tender in two bids system (technical

More information

Guide to Portfolio Rate Capture in Flexible Scenario Format

Guide to Portfolio Rate Capture in Flexible Scenario Format Guide to Portfolio Rate Capture in Flexible Scenario Format GGY AXIS 5001 Yonge Street Suite 1300 Toronto, ON M2N 6P6 Phone: 416-250-6777 Toll free: 1-877-GGY-AXIS Fax: 416-250-6776 Email: axis@ggy.com

More information

Application of Esscher Transformed Laplace Distribution in Microarray Gene Expression Data

Application of Esscher Transformed Laplace Distribution in Microarray Gene Expression Data Journal of Modern Applied Statistical Methods Volume 15 Issue 1 Article 31 5-1-016 Application of Esscher Transformed Laplace Distribution in Microarray Gene Expression Data Shanmugasundaram Devika Christian

More information

Second Quarter 2015 Results Summary

Second Quarter 2015 Results Summary Second Quarter 2015 Results Summary Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding expectations

More information

147 Small-Cap Research

147 Small-Cap Research 147 Small-Cap Research April 2, 2015 Grant Zeng, CFA 312-265-9466 Grant gzeng@zacks.com Zeng scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Pressure Biosciences (PBIO-OTCQB) PBIO: Record revenue

More information

ANNU UAL L REP E ORT 2016

ANNU UAL L REP E ORT 2016 Bio-Rad Laboratories ANNUAL REP ORT 2016 ACCELERATING SCIENTIFIC DISCOVERY AND IMPROVING HEALTHCARE Letter to our Shareholders We ended the year having accomplished many of the tasks we set out to do.

More information

An evaluation of the genome alignment landscape

An evaluation of the genome alignment landscape An evaluation of the genome alignment landscape Alexandre Fonseca KTH Royal Institute of Technology December 16, 2013 Introduction Evaluation Setup Results Conclusion Genetic Research Motivation Objective

More information

Our mission is to enable our customers to make the world healthier, cleaner and safer.

Our mission is to enable our customers to make the world healthier, cleaner and safer. 2015 ANNUAL REPORT Our mission is to enable our customers to make the world healthier, cleaner and safer. Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenue

More information

MYAITREND. The World s First Free AI Stock Analyst. User Guide

MYAITREND. The World s First Free AI Stock Analyst. User Guide MYAITREND The World s First Free AI Stock Analyst User Guide MYAITREND User Guide MyAiTrend LLC E-Mail: support@myaitrend.com Table of Contents The First Free AI Stock Analyst... 2 Three Important Principles

More information

Citi Support: Techniques for Establishing a Successful Audit Process

Citi Support: Techniques for Establishing a Successful Audit Process GSA SmartPay Conference Citi Support: Techniques for Establishing a Successful Audit Process David Ruda Product Manager / Director, Citi 11 th Annual GSA SmartPay Conference Phoenix, Arizona July 28 th

More information

Tecan Annual Report Advancing

Tecan Annual Report Advancing Tecan Annual Report 2016 Advancing Prepared for the century of biology The last century saw massive changes in the human condition, especially in our understanding and harnessing of the physical world.

More information

A MESSAGE FROM CAROLINE C. WHITACRE

A MESSAGE FROM CAROLINE C. WHITACRE A MESSAGE FROM CAROLINE C. WHITACRE The research community has been very successful in recent years in obtaining significant federal dollars to support our research programs. These funds come with the

More information

Alaska Sustainable Salmon Fund Statement of Work Revision #2: Extend end date to 1/31/18; amend objectives; revise budget

Alaska Sustainable Salmon Fund Statement of Work Revision #2: Extend end date to 1/31/18; amend objectives; revise budget Alaska Sustainable Salmon Fund Statement of Work Revision #2: Extend end date to 1/31/18; amend objectives; revise budget I. Project Title: Northern Cook Inlet Chinook Salmon Marine Harvest II. Project

More information

FLUIDIGM ANNOUNCES SECOND QUARTER FINANCIAL RESULTS

FLUIDIGM ANNOUNCES SECOND QUARTER FINANCIAL RESULTS FLUIDIGM ANNOUNCES SECOND QUARTER FINANCIAL RESULTS SOUTH SAN FRANCISCO, Calif., August 4, 2016 Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June

More information

Improving Return on Investment in Liquid Chromatography with the InfinityLab LC Series

Improving Return on Investment in Liquid Chromatography with the InfinityLab LC Series White Paper Improving Return on Investment in Liquid Chromatography with the InfinityLab LC Series Incremental Economic Value of the Agilent 1260 Infinity II Prime LC Introduction Agilent InfinityLab LC

More information

interim report january-june 2012 Vitrolife AB (publ)

interim report january-june 2012 Vitrolife AB (publ) interim report january-june 2012 Vitrolife AB (publ) Vitrolife is a global biotechnology/medical device Group that works in the areas of Fertility and Transplantation. The Fertility product area works

More information

TRADE SIGNALS POWERED BY AUTOCHARTIST

TRADE SIGNALS POWERED BY AUTOCHARTIST SAXO TRADER GO TRADE SIGNALS POWERED BY AUTOCHARTIST Trade Signals is a SaxoTraderGO tool that uses Autochartist technology to identify emerging and completed patterns in most leading financial markets.

More information

TRADE SIGNALS POWERED BY AUTOCHARTIST

TRADE SIGNALS POWERED BY AUTOCHARTIST SAXO TRADER GO TRADE SIGNALS POWERED BY AUTOCHARTIST Trade Signals is a SaxoTraderGO tool that uses Autochartist technology to identify emerging and completed patterns in most leading financial markets.

More information

multi asset funded trading programme

multi asset funded trading programme multi asset funded trading programme Trade Simple Trade Smart is a financial markets trading education company based in london. Our trading methods focus on: With a combined trading experience of over

More information

List of Standard Operating Procedures

List of Standard Operating Procedures 1000 Series: Safety and Quality Assurance QM CHP SVL 1001 SVL 1002 SVL 1004 SVL 1005 SVL 1007 SVL 1008 SVL 1010 SVL 1011 SVL 1015 SVL 1017 SVL 1019 SVL 1020 SVL 1021 SVL 1023 SVL 1025 SVL 1026 SVL 1027

More information

interim report january-september 2018 Vitrolife AB (publ)

interim report january-september 2018 Vitrolife AB (publ) interim report january-september Vitrolife AB (publ) Vitrolife is an international medical device Group. Vitrolife develops, produces and markets products for assisted reproduction. Vitrolife has approximately

More information

NuSep Raises $1.2m under SPP

NuSep Raises $1.2m under SPP FOR IMMEDIATE RELEASE NuSep Raises $1.2m under SPP Sydney, Australia 26 th August 2013 NuSep Holdings Ltd (ASX:NSP) wishes to advise that it has raised a total of $1,193,120 under the 2013 Share Purchase

More information

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers

A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers A Trusted Technology Partner to Medical and Advanced Technology Equipment Manufacturers Baird Industrial Conference, November 2017 Matthijs Glastra, Chief Executive Officer NASDAQ: NOVT 1 Safe Harbor Statement

More information

PUF 8 functions redundantly with GLD 1 to promote the meiotic progression of spermatocytes in Caenorhabditis elegans

PUF 8 functions redundantly with GLD 1 to promote the meiotic progression of spermatocytes in Caenorhabditis elegans PUF 8 functions redundantly with GLD 1 to promote the meiotic progression of spermatocytes in Caenorhabditis elegans Agarwal Priti * and Kuppuswamy Subramaniam *,, 1 * Department of Biological Sciences

More information

Q4 08 Earnings Call. Kevin Hrusovsky President & CEO. March 12, 2009

Q4 08 Earnings Call. Kevin Hrusovsky President & CEO. March 12, 2009 Q4 08 Earnings Call Kevin Hrusovsky President & CEO March 12, 2009 1 Agenda Highlights Strategic Roadmap Growth by SBU 2008 and 2009 Q4 08 and Q1 09 Growth Catalysts 2010+ Value Creation Catalysts 2009

More information

Hartford Investment Management Company

Hartford Investment Management Company Xenomorph Case Study Hartford Investment Management Company Many other firms still believe that having the best-of-breed analytics solves their risk management problems unfortunately this is only part

More information

MARKET REACTION TO & ANTICIPATION OF ACCOUNTING NUMBERS

MARKET REACTION TO & ANTICIPATION OF ACCOUNTING NUMBERS MARKET REACTION TO & ANTICIPATION OF ACCOUNTING NUMBERS One way in which accounting numbers can be assessed is to see how they relate to stock returns. Accounting numbers which update the market s beliefs

More information

Systematic Annotation

Systematic Annotation 4/5/2012 Review RTFM PNAS 95:14863 The Gene Ontology Three directed acyclic graphs (aspects): Biological Process Molecular Function Subcellular Component The Gene Ontology The Gene Ontology The AmiGO browser

More information